We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...

Dr. Kam Shojania, MD FRCPC, Rheumatologist, discusses osteoporosis management. Samuel Alito Comment During Obamacare Supreme ...

Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe ...

Osteoporosis is the most common bone disease in the U.S., leading to increased risk of fractures and a weakening of bone strength and structure. Now, new guidelines on who should be tested could lead ...

That means that if you aren’t currently doing anything to preserve your bones, your risk for osteoporosis is increasing.

Health care professionals should assess baseline bone mineral density in patients with osteoporosis before determining ...

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

Osteoporosis can be defined as a condition in which the quality of the structure of bones changes when bone mineral density ...

Huo Xue Tong Luo Capsule (HXTL) has been clinically used to treat osteonecrosis of the femoral head, osteoporosis, and other bone and joint diseases with promising effects.